{"nct_id":"NCT03176264","title":"PDR001 in Combination With Bevacizumab and mFOLFOX6 as First Line Therapy in Patients With Metastatic MSS Colorectal Cancer","status":"TERMINATED","status_verified_date":"2021-10","start_date":"2017-09-25","start_date_type":"ACTUAL","primary_completion_date":"2018-01-30","primary_completion_date_type":"ACTUAL","completion_date":"2018-01-30","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NVS"]}